Refining Approaches to Overcome Challenges, Enhance Consistency, and Standardize Scoring and Reporting in HER2-Expressing Solid Tumors

Refining Approaches to Overcome Challenges, Enhance Consistency, and Standardize Scoring and Reporting in HER2-Expressing Solid Tumors

Join us for this interactive symposium in conjunction with USCAP 2025 in which a panel of pathologists and medical oncologists will discuss the nuances of HER2 testing across GI lung and other solid tumors and the impact of testing results on treatment selection To register for the inperson meeting please register here https2025amuscaporg

  • Provider:Clinical Care Options
  • Activity Link: https://clinicaloptions.com/events/her2-pathology/her2-pathology/16385-23396
  • Start Date: 2025-03-26 05:00:00
  • End Date: 2025-03-26 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • MOC Credit Details: ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
    ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: AstraZeneca (Any division) - Amount: 65000.0 - Is Kind Support: False Source: Daiichi Sankyo, Inc. - Amount: 72500.0 - Is Kind Support: False Source: Jazz Pharmaceuticals, Inc. - Amount: 25000.0 - Is Kind Support: False
  • Activity Type: Live Course
  • CME Finder Type: Conference
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Breast, Internal Medicine, Medical Oncology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.